Skip to main content

View full-text article in PMC

. 2023 Mar 2;9:e42350. doi: 10.2196/42350

Table 4.

Annual outpatient expense compared by gender.^a

Gender	Study group
	Cancer groups (ICD-9-CM^b)									Comparison group
	Hematologic cancer (200-208) (n=3934)	P value^c	Brain cancer (191-192) (n=2241)	P value^c	Benign brain tumor (225) (n=7825)	P value^c	Non-CNS^d solid tumor (140-190; 193-199) (n=19,105)	P value^c	No cancer individuals (n=64,754)		P value^c
Female	255.92 (163.12-401.30)	N/A^e	492.35 (250.84-1364.01)	N/A	311.17 (189.30-538.72)	N/A	256.09 (160.60-410.86)	N/A	201.67 (126.46-309.05)		N/A
Male	208.57 (123.75-342.92)	<.001	458.34 (193.74-1404.03)	.06	237.66 (134.68-469.39)	<.001	192.07 (111.78-322.92)	<.001	153.35 (88.48-252.09)		<.001

^aData represent the median expense in US $ per person per year (IQR).

^bICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification.

^cCompared with females in each group.

^dCNS: central nervous system.

^eN/A: not applicable.